InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding InflaRx N.V. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 39 | 37 | −2 |
| Shares | 17.1M | 13.8M | −3.24M (−19.0%) |
| Value | $27.8M | $21.3M | −$6.52M (−23.4%) |
New holders (7)
Institutions that held InflaRx N.V. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prelude Capital Management, LLC | 194,465 | $299.5K | 0.02% |
| Jane Street Group, LLC | 46,515 | $71.6K | 0.00% |
| XTX Topco Ltd | 23,153 | $35.7K | 0.00% |
| Toroso Investments, LLC | 15,153 | $23.3K | 0.00% |
| Balyasny Asset Management LLC | 12,534 | $19.3K | 0.00% |
| Engineers Gate Manager LP | 12,251 | $18.9K | 0.00% |
| Qube Research & Technologies Ltd | 770 | $1.19K | 0.00% |
Sold out (9)
Institutions that held InflaRx N.V. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Point72 Asset Management, L.P. | 2,206,893 | $3.60M |
| Invesco Ltd. | 320,246 | $522.0K |
| Affinity Asset Advisors, LLC | 200,097 | $326.2K |
| Two Sigma Advisers, LP | 24,900 | $40.6K |
| Virtu Financial LLC | 21,299 | $35.0K |
| Susquehanna International Group, LLP | 16,966 | $27.7K |
| Cubist Systematic Strategies, LLC | 6,705 | $10.9K |
| JPMorgan Chase & Co | 645 | $1.05K |
| Harbour Investments, Inc. | 100 | $163 |